COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 2292: Articles 22911-22920  | Next

First report of tocilizumab use in a cohort of Latin American patients hospitalized for severe COVID-19 pneumonia
Valenzuela, O., Ibanez, S. E., Poli, M., Roessler, P., Aylwin, M., Roizen, G., Iruretagoyena, M., Agar, V., Donoso, J., Fierro, M., Montes, J.
10.1101/2020.08.12.20173104 — Posted: 2020-08-14
Comprehensive Systematic Review to Identify putative COVID-19 Treatments: Roles for Immunomodulator and Antiviral Treatments
Hill, T., Baker, M., Isherwood, L., Lee, L. Y.
10.1101/2020.08.13.20174060 — Posted: 2020-08-14
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults
Ward, H., Atchison, C. J., Whitaker, M., Ainslie, K. E. C., Elliot, J., Okell, L. C., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., Darzi, A., Cooke, G., Riley, S., Elliot, P.
10.1101/2020.08.12.20173690 — Posted: 2020-08-14 Discussion: Onsite
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York
Maru, S., Patil, U., Carroll-Bennett, R., Baum, A., Bohn-Hemmerdinger, T., Ditchik, A., Scanlon, M., Krishnan, P., Bogaert, K., Woodbury, C., Maru, D., Noble, L., Wasserman, R., Brown, B., Vreeman, R., Masci, J.
10.1101/2020.08.12.20171694 — Posted: 2020-08-14
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort.
Arnold, D. T., Hamilton, F. W., Milne, A., Morley, A., Viner, J., Attwood, M., Noel, A., Gunning, S., Hatrick, J., Hamilton, S., Elvers, K. T., Hyams, C., Bibby, A., Moran, E., Adamali, H., Dodd, J., Maskell, N. A., Barratt, S.
10.1101/2020.08.12.20173526 — Posted: 2020-08-14
ASSOCIATION BETWEEN ETHNICITY AND SEVERE COVID-19 DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Raharja, A., Tamara, A., Kok, L. T.
10.1101/2020.08.12.20157271 — Posted: 2020-08-14
Superspreading k-cores at the center of COVID-19 pandemic persistence
Serafino, M., Monteiro, H. S., Luo, S., Reis, S. D. S., Igual, C., Lima Neto, A. S., Travizano, M., Andrade, J. S., Makse, H. A.
10.1101/2020.08.12.20173476 — Posted: 2020-08-14
Immediate Effects of COVID-19 Outbreak on Psychiatric Outpatients: Posttraumatic Stress and Influencing Factors
Poyraz, B. C., Aksoy Poyraz, C., Turan, S., Demirel, O. F., Kavla, Y., Bulu, E., Hacisalihoglu, I., Ersungur, E. B.
10.1101/2020.08.12.20173468 — Posted: 2020-08-14
Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations
Nam, Y., Yun, J.-S., Lee, S. M., Park, J. W., Chen, Z., Lee, B., Verma, A., Ning, X., Shen, L., Kim, D.
10.1101/2020.08.11.20173120 — Posted: 2020-08-14
knowledge, attitudes and practices (KAP) towards Covid-19 among Palestinians during the Covid-19 outbreak: a cross sectional survey
Qutob, N., Awartani, F.
10.1101/2020.08.12.20170852 — Posted: 2020-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).